{
    "answer": "Full year 2024: Immunology segment sales were USD 9,293 million (or $9.293 billion). This represents an increase of +4% on a reported basis (from $16.6 billion in 2023 Cosentyx Total Net Sales reported by Novartis, according to press releases for Q4 2023 and full year 2023 results) but an increase of +8.96% on a constant currency basis (from the $50.3 billion in FY 2023 (reported in Q4 2023 results) to the $9.293 billion in Full Year 2024 Conservative Currency Segment Sales (found in a Novartis article).",
    "ground_truth": "$6,141,000,000; 23% increase (reported); 25% increase (constant currency)",
    "rewards": [
        0,
        0,
        0,
        0,
        0,
        0,
        0
    ],
    "reward_sum": 0,
    "turns": 7,
    "search count": 5,
    "script count": 0,
    "summary count": 0,
    "context lengths": [
        1026,
        1367,
        1715,
        3899,
        4436,
        6229,
        8138
    ]
}